Smith Scott E 4

Accession 0001179110-13-000081

CIK 0001222244other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:15 PM ET

Size

25.1 KB

Accession

0001179110-13-000081

Form 4

Period: 2012-12-28

Director

Transactions

Exercise/Conversion
Common Stock, $0.00001 par value
2012-12-28$1.10/sh+3,272$3,599→ 196,193 total
Exercise/Conversion
Convertible Note
2012-12-28$1.00/sh−3,272$3,272
Exercise: $1.10Exp: 2012-08-28→ Common stock, $0.00001 par value (3,272 underlying)
Exercise/Conversion
Common stock, $0.00001 par value
2012-12-28$0.50/sh+10,000$5,000→ 181,202 total
Award
Common Stock, $0.00001 par value
2012-12-28$0.64/sh+11,719$7,500→ 192,921 total
Exercise/Conversion
Warrants
2012-12-28−7,000→ 0 total
Exercise: $0.50Exp: 2012-12-31→ Common Stock, $0.00001 par value (7,000 underlying)

Holdings

Warrants
Exercise: $1.30Exp: 2013-07-12→ Common stock, $0.00001 par value (32,475 underlying)
32,475
Options
Exercise: $1.72Exp: 2017-08-10→ Common stock $0.00001 par value (14,535 underlying)
14,535
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (30,000 underlying)
30,000
Stock options
Exercise: $0.87Exp: 2018-08-09→ Common stock, $0.00001 par value (28,736 underlying)
28,736
Stock Options
Exercise: $0.60Exp: 2019-08-09→ Common stock, $0.00001 par value (25,000 underlying)
25,000
Stock Options
Exercise: $7.00Exp: 2013-05-30→ Common Stock, $0.00001 par value (3,000 underlying)
3,000
Warrants
Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (10,000 underlying)
10,000
Stock Options
Exercise: $1.00Exp: 2015-08-12→ Common stock, $0.00001 par value (1,000 underlying)
1,000
Stock Options
Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (20,000 underlying)
20,000

Footnotes (6)

[F1]Currently exercisable.
[F2]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over 12 months.
[F3]On December 28, 2012, the reporting person converted a convertible promissory note in the principal amount of $2,900, along with accrued interest thereon of $699, into common shares pursuant to the terms of the note. The transaction was approved by the Company's Board of Directors and is exempt under section 16b-3(d).
[F4]Shares issued to directors in payment of directors' fees earned during the period from July 1, 2012 and December 31, 2012, in lieu of cash. The Issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rule 16b-3(d).
[F5]Exercise of warrants at $0.50 per share.
[F6]The exercise price had previously been reported as $0.70 per share in error. The correct exercise price is $0.50 per share, which was amended on a Form 4/A filed concurrently with this Form 4.

Documents

1 file

ProUroCare Medical Inc.

CIK 0001222244

Entity typeother